Zai Lab appoints Joshua Smiley as COO effective August 1, 2022

Zai Lab Ltd

Joshua Smiley appointed Chief Operating Officer, effective August 1, 2022, reporting to CEO Samantha Du.
Smiley brings 26 years biopharma experience, most recently as SVP and CFO at Eli Lilly.
He will oversee business, finance, and global operations; based in Cambridge, Massachusetts.
CEO Dr. Du said Smiley will be instrumental in expanding geographies and diversifying financial footprint.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joshua Smiley

Chief Operating Officer

ZLAB · Zai Lab Ltd

Effective: 2022-08-01
Filed: March 15, 2022, 7:59 PM ET

On March 15, 2022, Zai Lab Limited (the “Company”) announced the appointment of Joshua Smiley as the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joshua Smiley was appointed as Chief Operating Officer at Zai Lab Ltd.

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On March 15, 2022, Zai Lab Limited (the “Company”) announced the appointment of Joshua Smiley as the Company’s Chief Operating Officer.

View on SEC.gov

Zai Lab Ltd filing history →

Source: SEC EDGAR

accession 0001193125-22-075434

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.